deoxyglucose has been researched along with Acute Confusional Senile Dementia in 135 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 49 (36.30) | 18.7374 |
1990's | 64 (47.41) | 18.2507 |
2000's | 10 (7.41) | 29.6817 |
2010's | 10 (7.41) | 24.3611 |
2020's | 2 (1.48) | 2.80 |
Authors | Studies |
---|---|
Balkaya, M; Chen, Y; Cheng, Y; Cho, S; Corona, C; Geschwind, DH; Karuppagounder, SS; Kawaguchi, R; Kumar, A; Ming, GL; Ratan, RR; Sagdullaev, BT; Stuart, C; Timmusk, T; Tuvikene, J; Wen, Z | 1 |
Fan, Q; Fu, Y; Liu, L; Liu, Y; Ma, H; Seeram, NP; Wang, P; Wang, X; Zhang, Z; Zheng, J; Zhou, F | 1 |
Hata, J; Hirakawa, Y; Kishimoto, H; Kitazono, T; Kiyohara, Y; Koga, M; Mukai, N; Nakamura, U; Ninomiya, T; Ohara, T; Yoshida, D | 1 |
Chappell, M; Forloni, G; Micotti, E; Serra, SC; Snellman, A; Tolomeo, D | 1 |
Boerema, AS; Hoozemans, JJ; Nölle, A; Scheper, W; Strijkstra, AM; van der Harg, JM; van Haastert, ES; Zwart, R | 1 |
Bard, F; Beglopoulos, V; Daumas, S; Fan, Z; Ferrington, L; Hyman, BT; Kelly, PA; Morris, RG; Roe, AD; Tulloch, J; Watson, R | 1 |
Di Meco, A; Lauretti, E; Li, JG; Praticò, D | 1 |
Bembinster, LA; Bennett, DA; Cole, SL; De Strooper, B; Eimer, WA; Haass, C; Hébert, SS; Hitt, B; Lammich, S; Lichtenthaler, SF; Maus, E; O'Connor, T; Sadleir, KR; Vassar, R; Velliquette, RA; Zhao, J | 1 |
Bonvento, G; Delatour, B; Delzescaux, T; Dhenain, M; Dubois, A; Hantraye, P; Hérard, AS | 1 |
Abeti, R; Abramov, AY; Duchen, MR | 1 |
Brinton, RD; Cadenas, E; Chen, S; Mao, Z; Yao, J | 1 |
Blomquist, G; Engler, H; Forsberg, A; Långström, B; Nordberg, A | 1 |
Dey, CS; Gupta, A | 1 |
Buijs, RM; Dai, J; Kamphorst, W; Swaab, DF | 1 |
Arnold, SE; Barbas, NR; Clark, CM; DeCarli, CS; Foster, NL; Heidebrink, JL; Higdon, R; Jagust, WJ; Koeppe, RA; Minoshima, S; Turner, RS | 1 |
Chui, DH; Ishiguro, K; Launey, T; Miyasaka, T; Murayama, O; Planel, E; Sato, S; Takashima, A; Tanemura, K; Tatebayashi, Y | 1 |
da Cruz e Silva, EF; da Cruz e Silva, OA; Domingues, SC; Fardilha, M; Henriques, AG | 1 |
Feinstein, DL; Galea, E; Lacombe, P | 1 |
Da Cruz e Silva, EF; Da Cruz e Silva, OA; Domingues, SC; Henriques, AG; Wu, W | 1 |
Batbayli, M; Holm, IE; Law, I; Lindquist, SG; Nielsen, JE; Schwartz, M; Stokholm, J; Waldemar, G | 1 |
Mazziotta, JC; Phelps, ME; Schelbert, HR | 1 |
Creasey, H; Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Rapoport, SI; Schapiro, MB | 1 |
Kameyama, M; Kuhl, DE; Metter, EJ; Phelps, ME; Riege, WH | 1 |
Brant-Zawadzki, M; Budinger, TF; Friedland, RP; Jagust, WJ | 1 |
Brooks, R; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Mansi, L; Patronas, NJ | 1 |
Arnaud, P; Fudenberg, HH; Hames, CG; Khansari, N; Tsang, KY; Whitten, HD | 1 |
Bert, J; Bouras, C; Gorde-Durand, JM; Grégoire, N; Nezri, C; Salamon, G | 1 |
Fibiger, HC; Lamarca, MV | 1 |
Budinger, TF; Derenzo, SE; Friedland, RP; Ganz, E; Huesman, RH; Koss, B; Mathis, CA; Ober, BA; Yano, Y | 1 |
Brooks, RA; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Patronas, NJ | 1 |
Christman, DR; de Leon, MJ; Ferris, SH; Fowler, JS; George, AE; Reisberg, B; Wolf, AP; Yonekura, Y | 1 |
Benson, DF; Cummings, JL; Hawkins, RA; Kuhl, DE; Phelps, ME; Tsai, SY | 1 |
Brooks, R; Chase, TN; Di Chiro, G; Fedio, P; Foster, NL; Kessler, R; Mansi, L | 1 |
Alavi, A; Christman, DR; De Leon, MJ; Farkas, T; Ferris, SH; Fowler, JS; George, AE; Reisberg, B; Reivich, M; Wolf, AP | 1 |
Heiss, WD; Herholz, K; Mielke, R; Szelies, B | 1 |
Fink, G; Heiss, WD; Herholz, K; Kessler, J; Mielke, R | 1 |
Baron, JC; Barré, L; Eustache, F; Lambert, J; Lechevalier, B; Morin, P; Penniello, MJ; Petit-Taboué, MC; Viader, F | 1 |
Frackowiak, RS; Kennedy, AM; Rossor, MN | 1 |
Herholz, K | 1 |
Chase, TN; Tamminga, CA | 1 |
Grond, M; Heiss, WD; Mielke, R; Szelies, B | 1 |
Buchsbaum, MS; Evans, WJ; Guich, S; Nguyen, D; Nguyen, P; Rice, D; Siegel, BV; Stanley, J; Starr, A; Valladares-Neto, DC | 1 |
Azari, NP; Pietrini, P | 1 |
Foster, NL; Frey, KA; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
Akashi, Y; Fukumura, T; Ichimiya, A; Ichiya, Y; Kuwabara, Y; Masuda, K; Sasaki, M; Yoshida, T | 1 |
Kerwin, R | 1 |
Fink, GR; Heiss, WD; Herholz, K; Ichimiya, A; Jacobs, A; Kessler, J; Mielke, R; Pietrzyk, U | 1 |
Foster, NL; Frey, KA; Koeppe, RA; Kuhl, DE; Meyer, M | 1 |
Mayberg, HS | 1 |
Jagust, WJ | 1 |
Heiss, WD; Herholz, K; Ichimiya, A; Kessler, J; Mielke, R; Slansky, I | 1 |
Blin, J; Chase, TN; Giuffra, ME; Mouradian, MM; Piercey, MF | 1 |
Frey, KA; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
Frey, KA; Ishihara, M; Koeppe, RA; Kuhl, DE; Minoshima, S | 1 |
Heiss, WD; Herholz, K; Kessler, J; Mielke, R; Slansky, I; Szelies, B | 1 |
Fukuyama, H; Kimura, J; Konishi, J; Ogawa, M; Yamaguchi, S; Yamauchi, H; Yonekura, Y | 1 |
Barker, WW; Duara, R; Grady, C; Kippenhan, JS; Nagel, J | 1 |
Del Sole, A; Franceschi, M; Gilardi, MC; Grassi, F; Lucignani, G; Messa, C; Perani, D; Rizzo, G; Zenorini, A; Zito, F | 1 |
Hijdra, A; Scheltens, P; van Royen, EA; Weinstein, HC | 1 |
Comar, D; Fazio, F; Franck, G; Heiss, WD; Herholz, K; Perani, D; Salmon, E | 1 |
Alavi, A; Berlin, JA; Newberg, AB; Souder, E | 1 |
Azari, NP; Grady, CL; Haxby, JV; Heston, LL; Horwitz, B; Pettigrew, KD; Pietrini, P; Rapoport, SI; Salerno, JA; Schapiro, MB | 1 |
Foster, NL; Frey, KA; Groom, GN; Junck, L; Kuhl, DE | 1 |
Berisford, MA; Cummings, JL; Hinkin, CH; Mahler, ME; Mandelkern, MA; Sultzer, DL; Van Gorp, WG | 1 |
Ghaemi, M; Heiss, WD; Herholz, K; Kessler, J; Mielke, R | 1 |
Berent, S; Giordani, B; Koeppe, RA; Kuhl, DE; Piert, M | 1 |
Carr, CA; Fischman, AJ; González, RG; Growdon, JH; Guimaraes, AR; Halpern, EF; Rosen, BR; Stern, CE | 1 |
Ishii, K; Jamzad, M; Senda, M; Toyama, H | 1 |
Alexander, GE; Dani, A; Freo, U; Furey, ML; Grady, CL; Graff-Radford, N; Mentis, MJ; Pietrini, P; Schapiro, MB | 1 |
Alexander, GE; Brady, DR; Furey, ML; Grady, CL; Mentis, MJ; Pietrini, P; Schapiro, MB | 1 |
Albin, RL; Berent, S; Foster, NL; Frey, KA; Giordani, B; Koeppe, RA; Kuhl, DE; Minoshima, S; Vander Borght, T | 1 |
Ishii, K; Kitagaki, H; Matsuda, K; Mori, E; Sakamoto, S; Sasaki, M; Yamaji, S | 1 |
Berent, S; Foster, NL; Frey, KA; Giordani, B; Kuhl, DE; Minoshima, S | 1 |
Alexander, GE; Dani, A; Freo, U; Furey, ML; Grady, CL; Haxby, JV; Horwitz, B; Mangot, D; Mentis, MJ; Pietrini, P; Schapiro, MB; Simon, EW | 1 |
Freedman, ML; Marcus, DL | 1 |
Ishii, K; Kitagaki, H; Mori, E; Mori, T; Sakamoto, S; Sasaki, M; Yamaji, S | 1 |
Bales, KR; Dodart, JC; Mathis, C; Paul, SM; Ungerer, A | 1 |
Alberici, AC; Benussi, L; Binetti, G; Gasparini, L; Ghidoni, R; Growdon, JH; Moratto, D; Nitsch, RM; Trabucchi, M | 1 |
Browne, SE; Georgievska, B; Isacson, O; Lin, L; Mattsson, A | 1 |
Barker, WW; Chang, J; Duara, R; Loewenstein, DA; Pascal, S; Yoshii, F | 1 |
Fairbanks, LA; Guze, BH; Mandelkern, MA; Min, CA; Small, GW; Stern, CE | 1 |
Braun, A; Chase, TN; Coppola, R; Gibson, R; Gorey, J; Jones, D; Mann, U; Reba, RC; Weinberger, DR | 1 |
Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K | 1 |
Blomqvist, G; Nybäck, H; Nyman, H; Sjögren, I; Stone-Elander, S | 1 |
Baxter, LR; Guze, BH; Hoffman, JM; Mazziotta, JC; Phelps, ME | 3 |
Heiss, WD; Herholz, K; Kessler, J; Szelies, B | 1 |
Baxter, LR; Guze, BH; Mazziotta, JC; Phelps, ME; Schwartz, JM; Szuba, MP | 1 |
Fukuyama, H; Harada, K; Kameyama, M; Kimura, J; Konishi, J; Miyoshi, T; Senda, M; Yamaguchi, S; Yamauchi, H; Yonekura, Y | 1 |
Harik, SI; LaManna, JC | 1 |
Brandt, J; Burns, A; Folstein, MF; Frost, JJ; Harris, G; Mayberg, H; Sapp, J; Steele, C; Tune, L; Wagner, HN | 1 |
Buchsbaum, MS; Chui, H; Cotman, CW; Hazlett, E; Kesslak, JP; Lynch, G; Sicotte, N; Teng, E; Wu, J | 1 |
Budinger, TF; Coxson, PG; Huesman, RH; Jagust, WJ; Mathis, CA; Reed, BR; Seab, JP; Valk, PE | 1 |
Friedland, RP; Grady, C; Haxby, JV; Kumar, A; Rapoport, SI; Salerno, JA; Schapiro, MB; Wagner, E | 1 |
Blin, J; Chase, TN; Claus, JJ; Giuffra, M; Ludwig, C; Mohr, E | 1 |
Grond, M; Heiss, WD; Herholz, K; Kessler, J | 1 |
Hatazawa, J; Itoh, M; Kinomura, S; Matsui, H; Matsuzawa, T; Meguro, K; Ueda, M; Yamada, K; Yamaguchi, T | 1 |
Friedland, RP; Grady, CL; Haxby, JV; Kumar, A; Schapiro, MB | 1 |
Akiyama, H; Beattie, BL; Calne, DB; Crockett, D; Harrop, R; McGeer, EG; McGeer, PL; Parks, R; Peppard, RP; Tuokko, H | 1 |
Budinger, TF; Derenzo, SE; Geyer, AB; Huesman, RH; Jagust, WJ; Valk, PE | 1 |
Heiss, WD; Herholz, K; Pawlik, G; Szelies, B; Wienhard, K | 1 |
de Leon, MJ; Ferris, SH; Franssen, E; George, AE; Kluger, A; Wolf, AP | 1 |
Barker, W; Bowen, B; Duara, R; Loewenstein, D; Pascal, S | 1 |
Ashford, JW; Fujikawa, DG; Kuhl, DE; Mazziotta, JC; Metter, EJ; Riege, WH; Small, GW | 1 |
Christman, DR; de Leon, MJ; Fowler, JS; Goldman, J; Hunter, K; Logan, J; Marcus, DL; Pearson, J; Tsai, J; Wolf, AP | 1 |
Akiyama, H; Harrop, R; McGeer, EG; McGeer, PL; Peppard, R | 1 |
Akiyama, H; Harrop, R; McGeer, EG; McGeer, PL | 1 |
Budinger, TF; Friedland, RP; Huesman, RH; Jagust, WJ; Knittel, B; Koss, E; Mathis, CA; Mazoyer, BM; Ober, BA | 1 |
Farde, L; Nybäck, H; Persson, A; Sedvall, G | 1 |
Cutler, NR; Davies, P; Haxby, JV; Heston, LL; Schapiro, MB | 1 |
Benson, DF | 1 |
Cutler, NR | 1 |
Kuhl, DE; Markham, CH; Mazziotta, JC; Metter, EJ; Phelps, ME; Riege, WH | 1 |
Berg, G; Friedland, RP; Grady, CL; Haxby, JV; Horwitz, B; Rapoport, SI; Schapiro, M; Sundaram, M | 1 |
Chase, TN; Fedio, P; Foster, NL; Gillespie, MM; Patronas, NJ | 1 |
Cutler, NR; Duara, R; Grady, C; Haxby, J; Heston, L; Larson, S; Moore, A; Rapoport, SI; Schlageter, N; Sundaram, M | 1 |
Harrop, R; Kamo, H; Li, DK; Martin, WR; McGeer, EG; McGeer, PL; Pate, BD | 1 |
Brouwers, P; Chase, TN; Cox, C; Fedio, P; Foster, NL; Lalonde, F; Martin, A; Teleska, P | 1 |
de Leon, MJ; Ferris, SH; George, AE; Kluger, A; Miller, JD; Reisberg, B; Sachs, HJ; Wolf, AP | 1 |
Berg, G; Grady, C; Haxby, JV; Luxenberg, JS; May, C; Moore, A; Rapoport, SI; Robinette, D; White, BJ | 1 |
Duara, R; Grady, CL; Horwitz, B; Rapoport, SI; Schlageter, NL | 1 |
Agranoff, BW; Aldrich, MS; Berent, S; Foster, NL; Gilman, S; Hichwa, RH; Sackellares, JC; VanDerSpek, AF | 1 |
Brown, RT; Di Chiro, G; Feldman, RG; Nee, LE; Noble, H; Polinsky, RJ | 1 |
Battistin, L; Bracco, F; Dam, M; Pizzolato, G; Rigo, A | 1 |
Alavi, A; Alavi, J; Chawluk, J; Fazekas, F; Kushner, M; Reivich, M; Rosen, M; Tobin, M | 1 |
Berg, G; Grady, CL; Haxby, JV; Horwitz, B; Rapoport, SI | 1 |
Adam, MJ; Ammann, W; Beattie, BL; Calne, DB; Harrop, R; Kamo, H; Li, DK; McGeer, EG; McGeer, PL; Tuokko, H | 1 |
Budinger, TF; Friedland, RP; Koss, E; Ober, BA | 1 |
Friedland, RP; Jagust, WJ; Koss, E; Ober, BA | 1 |
Hawkins, RA; Kuhl, DE; Metter, EJ; Riege, WH | 1 |
Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Kay, AD; Kessler, RM; Rapoport, SI; Sundaram, M | 1 |
Cutler, NR; Duara, R; Grady, CL; Haxby, JV; Heston, L; Margolin, RM; Moore, AM; Parisi, JE; Rapoport, SI; White, J | 1 |
Budinger, TF; Friedland, RP; Jagust, WJ | 1 |
Kuhl, DE; Metter, EJ; Riege, WH | 1 |
9 review(s) available for deoxyglucose and Acute Confusional Senile Dementia
Article | Year |
---|---|
Positron computed tomography for studies of myocardial and cerebral function.
Topics: Alzheimer Disease; Animals; Brain; Brain Neoplasms; Cardiomyopathies; Cerebrovascular Disorders; Deoxyglucose; Dogs; Epilepsy; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Huntington Disease; Regional Blood Flow; Tomography, Emission-Computed | 1983 |
FDG PET and differential diagnosis of dementia.
Topics: Alzheimer Disease; Blood Glucose; Brain; Dementia; Dementia, Vascular; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1995 |
Clinical correlates of PET- and SPECT-identified defects in dementia.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Delusions; Dementia; Deoxyglucose; Depressive Disorder; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Severity of Illness Index; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 1994 |
Functional imaging in dementia: an overview.
Topics: Alzheimer Disease; Brain; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Neuro-imaging in the diagnosis of Alzheimer's disease. II. Positron and single photon emission tomography.
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1993 |
Functional brain imaging and Alzheimer-type dementia.
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Deoxyglucose; Female; Glucose; Humans; Male; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
[18F]-fluorodeoxyglucose (FDG) and positron emission tomography (PET) in aging and dementia. A decade of studies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Child; Deoxy Sugars; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radionuclide Imaging | 1989 |
NIH Conference. Alzheimer's disease and Down's syndrome: new insights.
Topics: Adult; Age Factors; Aged; Alzheimer Disease; Brain; Brain Chemistry; Cognition; Dementia; Deoxyglucose; Down Syndrome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Middle Aged; Neurotransmitter Agents; Parasympathetic Nervous System; Psychological Tests; Tomography, Emission-Computed | 1985 |
Positron emission tomography in patients with clinically diagnosed Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Cerebellar Cortex; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Oxygen; Psychological Tests; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Water | 1986 |
9 trial(s) available for deoxyglucose and Acute Confusional Senile Dementia
Article | Year |
---|---|
A comparison of classification methods for differentiating fronto-temporal dementia from Alzheimer's disease using FDG-PET imaging.
Topics: Alzheimer Disease; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Humans; Tomography, Emission-Computed | 2004 |
Dysfunction of visual cortex contributes to disturbed processing of visual information in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Deoxyglucose; Evoked Potentials, Visual; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mental Processes; Middle Aged; Psychometrics; Radiography; Tomography, Emission-Computed; Vision, Ocular; Visual Cortex | 1995 |
P300 in Alzheimer's disease: relationships to dementia severity and glucose metabolism.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Chemistry; Deoxyglucose; Electroencephalography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1995 |
EEG delta, positron emission tomography, and memory deficit in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain Mapping; Delta Rhythm; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory Disorders; Psychiatric Status Rating Scales; Temporal Lobe; Tomography, Emission-Computed | 1995 |
HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Topics: Aged; Aging; Alzheimer Disease; Brain; Cerebrovascular Circulation; Dementia, Vascular; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Organotechnetium Compounds; Oximes; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Organ Specificity; Physostigmine; Reference Values; Scopolamine; Tomography, Emission-Computed | 1994 |
Activation PET as an instrument to determine therapeutic efficacy in Alzheimer's disease.
Topics: Alzheimer Disease; Analysis of Variance; Brain; Cognition; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Neuropsychological Tests; Patient Education as Topic; Phosphatidylserines; Pyrithioxin; Social Support; Tomography, Emission-Computed | 1993 |
Physostigmine in Alzheimer's disease: effects on cognitive functioning, cerebral glucose metabolism analyzed by positron emission tomography and cerebral blood flow analyzed by single photon emission tomography.
Topics: Aged; Alzheimer Disease; Amphetamines; Blood Glucose; Brain; Cerebrovascular Circulation; Deoxyglucose; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Physostigmine; Pilot Projects; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1991 |
Nootropic drugs in Alzheimer's disease: symptomatic treatment with pramiracetam.
Topics: Aged; Alzheimer Disease; Deoxyglucose; Dose-Response Relationship, Drug; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuropsychological Tests; Psychiatric Status Rating Scales; Psychotropic Drugs; Pyrrolidines; Tomography, Emission-Computed | 1991 |
117 other study(ies) available for deoxyglucose and Acute Confusional Senile Dementia
Article | Year |
---|---|
2-Deoxyglucose drives plasticity via an adaptive ER stress-ATF4 pathway and elicits stroke recovery and Alzheimer's resilience.
Topics: Activating Transcription Factor 4; Alzheimer Disease; Brain-Derived Neurotrophic Factor; Deoxyglucose; Glucose; Humans; Ketosis; Stroke | 2023 |
Ginnalin A Inhibits Aggregation, Reverses Fibrillogenesis, and Alleviates Cytotoxicity of Amyloid β(1-42).
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Cell Survival; Circular Dichroism; Deoxyglucose; Gallic Acid; Humans; Peptide Fragments; Surface Plasmon Resonance | 2020 |
Alternative Measures of Hyperglycemia and Risk of Alzheimer's Disease in the Community: The Hisayama Study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Deoxyglucose; Female; Follow-Up Studies; Glucose Intolerance; Glycated Hemoglobin; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Hyperglycemia; Incidence; Independent Living; Japan; Male; Multivariate Analysis; Proportional Hazards Models; Prospective Studies; Risk Factors; Serum Albumin | 2017 |
Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Biological Transport; Brain; Deoxyglucose; Disease Models, Animal; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Mice | 2018 |
The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress.
Topics: Alzheimer Disease; Animals; Cell Line, Tumor; Cerebral Cortex; Cold Temperature; Corpus Striatum; Cricetinae; Deoxyglucose; eIF-2 Kinase; Endoribonucleases; Hippocampus; Humans; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Stress, Physiological; tau Proteins; Taurochenodeoxycholic Acid; Tunicamycin; Unfolded Protein Response | 2014 |
Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antibodies, Neutralizing; Biological Transport; Biomarkers; Brain; Brain Mapping; Deoxyglucose; Disease Models, Animal; Female; Gene Expression; Glucose; Humans; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Transgenes | 2016 |
Glucose deficit triggers tau pathology and synaptic dysfunction in a tauopathy mouse model.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Brain; CA1 Region, Hippocampal; Deoxyglucose; Disease Models, Animal; Excitatory Postsynaptic Potentials; Female; Glucose; Learning; Long-Term Potentiation; Male; Memory; Mice; Mice, Transgenic; Neurons; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Random Allocation; Synapses; tau Proteins; Tauopathies | 2017 |
Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.
Topics: Age Factors; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Antimetabolites; Aspartic Acid Endopeptidases; Cells, Cultured; Cerebral Cortex; Convulsants; Dactinomycin; Deoxyglucose; Disease Models, Animal; eIF-2 Kinase; Embryo, Mammalian; Enzyme Activation; Gene Expression Regulation; Glucose; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Nitro Compounds; Peptide Fragments; Phosphorylation; Plaque, Amyloid; Propionates; Protein Synthesis Inhibitors; Time Factors; Transcription Factors; Transfection | 2008 |
Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Autoradiography; Brain; Brain Mapping; Carbon Radioisotopes; Deoxyglucose; Disease Models, Animal; Glucose; Image Processing, Computer-Assisted; Mice; Mice, Transgenic; Positron-Emission Tomography; Presenilin-1; Radiopharmaceuticals | 2010 |
Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death.
Topics: 4-Chloro-7-nitrobenzofurazan; Age Factors; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Calcium; Cell Death; Coculture Techniques; Deoxyglucose; Disease Models, Animal; Glial Fibrillary Acidic Protein; Glucose; Hippocampus; Membrane Potential, Mitochondrial; Mice; Mice, Transgenic; NAD; NADPH Oxidases; Neurons; Oxygen Consumption; Peptide Fragments; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate | 2011 |
2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Deoxyglucose; Disease Models, Animal; Energy Metabolism; Female; Ketone Bodies; Mice; Mice, Transgenic; Mitochondria; Nerve Growth Factors; Neurons; Oxidative Stress; Up-Regulation | 2011 |
The use of PIB-PET as a dual pathological and functional biomarker in AD.
Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Biomarkers; Carbon Radioisotopes; Cognitive Dysfunction; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Regional Blood Flow; Thiazoles | 2012 |
PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Butadienes; Cell Line, Tumor; Deoxyglucose; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Inositol Polyphosphate 5-Phosphatases; Insulin; Insulin Resistance; MAP Kinase Signaling System; Mice; Neurons; Nitriles; Phosphatidylinositol 3-Kinases; Phosphatidylinositols; Phosphoric Monoester Hydrolases; Phosphorylation; Primary Cell Culture; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; RNA Interference | 2012 |
Impaired axonal transport of cortical neurons in Alzheimer's disease is associated with neuropathological changes.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Axonal Transport; Axons; Biotin; Cerebral Cortex; Deoxyglucose; Dextrans; Female; Fluorescent Dyes; Humans; In Vitro Techniques; Male; Middle Aged; Nerve Net; Neurofibrillary Tangles; Neurons; Plaque, Amyloid; Prefrontal Cortex; Sodium Azide; Temporal Lobe | 2002 |
Alterations in glucose metabolism induce hypothermia leading to tau hyperphosphorylation through differential inhibition of kinase and phosphatase activities: implications for Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Axons; Blood Glucose; Blotting, Western; Body Temperature; Cerebellum; Deoxyglucose; Glucose; Hypothermia; Insulin; Male; Mice; Mice, Inbred C57BL; Neocortex; Phosphoprotein Phosphatases; Phosphoric Monoester Hydrolases; Phosphorylation; Phosphotransferases; Protein Phosphatase 2; Starvation; tau Proteins | 2004 |
Sodium azide and 2-deoxy-D-glucose-induced cellular stress affects phosphorylation-dependent AbetaPP processing.
Topics: Adaptor Proteins, Signal Transducing; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Antimetabolites; Chlorocebus aethiops; COS Cells; Deoxyglucose; Enzyme Inhibitors; Mitogen-Activated Protein Kinase 8; Neurons; Oxidative Stress; PC12 Cells; Phosphoprotein Phosphatases; Phosphorylation; Rats; Reactive Oxygen Species; Signal Transduction; Sodium Azide; Tetradecanoylphorbol Acetate | 2005 |
Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice.
Topics: Alzheimer Disease; Analysis of Variance; Animals; Brain; Carbon Radioisotopes; Deoxyglucose; Disease Models, Animal; Female; Glucose; Heterozygote; Humans; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Pioglitazone; Thiazolidinediones; Transforming Growth Factor beta1 | 2006 |
Altered subcellular distribution of the Alzheimer's amyloid precursor protein under stress conditions.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Chlorocebus aethiops; COS Cells; Deoxyglucose; Endoplasmic Reticulum; Gene Expression Regulation; Golgi Apparatus; Green Fluorescent Proteins; Humans; Oxidative Stress; Phosphorylation; Protein Isoforms; Tetradecanoylphorbol Acetate | 2007 |
Alzheimer disease-like clinical phenotype in a family with FTDP-17 caused by a MAPT R406W mutation.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Arginine; Chromosomes, Human, Pair 17; Dementia; Denmark; Deoxyglucose; Family Health; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurofibrillary Tangles; Neuropsychological Tests; Peptide Fragments; Phenotype; Positron-Emission Tomography; tau Proteins; Tryptophan | 2008 |
NIH Conference. Brain imaging: aging and dementia.
Topics: Adult; Aged; Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Female; Fluorine; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Processes; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed; Wechsler Scales | 1984 |
Cerebral metabolic relationships for selected brain regions in Alzheimer's, Huntington's, and Parkinson's diseases.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Fluorine; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Radioisotopes | 1984 |
The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance.
Topics: Alzheimer Disease; Deoxyglucose; Fluorine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1984 |
Cortical abnormalities in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Psychological Tests; Temporal Lobe; Tomography, Emission-Computed | 1984 |
Immune diagnosis of a subset of Alzheimer's disease with preliminary implications for immunotherapy.
Topics: Adult; Aged; Alzheimer Disease; Deoxyglucose; Erythrocytes; Female; Humans; Immunologic Memory; Immunotherapy; Interleukin-1; Interleukin-2; Killer Cells, Natural; Male; Middle Aged; Rosette Formation; T-Lymphocytes | 1984 |
Cerebral metabolic changes induced by an unconventional agent: experimental model for some human degenerative diseases of the central nervous system.
Topics: Alzheimer Disease; Animals; Blood Glucose; Brain; Corpus Striatum; Cricetinae; Deoxyglucose; Disease Models, Animal; Humans; Mesocricetus; Prions; Scrapie; Sheep; Substantia Nigra | 1984 |
Deoxyglucose uptake and choline acetyltransferase activity in cerebral cortex following lesions of the nucleus basalis magnocellularis.
Topics: Alzheimer Disease; Animals; Basal Ganglia; Brain Diseases; Cerebral Cortex; Choline O-Acetyltransferase; Deoxyglucose; Disease Models, Animal; Glucose; Humans; Ibotenic Acid; Male; Pentobarbital; Rats; Substantia Innominata | 1984 |
Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radioisotopes; Tomography, Emission-Computed | 1983 |
Alzheimer's disease: focal cortical changes shown by positron emission tomography.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiography; Tomography, Emission-Computed | 1983 |
Positron emission tomography in dementia.
Topics: Aged; Alzheimer Disease; Basal Ganglia; Brain; Dementia; Deoxyglucose; Depression; Glucose; Humans; Tomography, Emission-Computed | 1983 |
The fluorodeoxyglucose 18F scan in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Alzheimer Disease; Brain; Dementia; Deoxy Sugars; Deoxyglucose; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radiography; Radioisotopes; Tomography, Emission-Computed | 1983 |
Cognitive and cerebral metabolic function in early and advanced Alzheimer's disease.
Topics: Alzheimer Disease; Blood Glucose; Cerebral Cortex; Cognition Disorders; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychometrics; Tomography, Emission-Computed; Wechsler Scales | 1984 |
18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Tomography, Emission-Computed | 1982 |
Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Dementia, Vascular; Deoxyglucose; Discriminant Analysis; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Tomography, Emission-Computed | 1994 |
A PET study of the functional neuroanatomy of writing impairment in Alzheimer's disease. The role of the left supramarginal and left angular gyri.
Topics: Aged; Agraphia; Alzheimer Disease; Cognition; Deoxyglucose; Glucose; Humans; Language; Middle Aged; Neuropsychological Tests; Parietal Lobe; Phonetics; Prospective Studies; Reading; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1995 |
Positron emission tomography in familial Alzheimer disease.
Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Blood Glucose; Brain; Chromosomes, Human, Pair 14; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Linkage; Humans; Longitudinal Studies; Phenotype; Risk Factors; Tomography, Emission-Computed | 1995 |
Alzheimer's dementia.
Topics: Adult; Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Tomography, Emission-Computed | 1995 |
Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?
Topics: Adult; Alzheimer Disease; Basal Ganglia Diseases; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Tomography, Emission-Computed | 1995 |
A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Sensitivity and Specificity; Stereotaxic Techniques; Tomography, Emission-Computed | 1995 |
[A longitudinal study of CMRGlu in dementia of Alzheimer type].
Topics: Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Time Factors; Tomography, Emission-Computed | 1994 |
Functional neuroimaging in Alzheimer's disease: how far should we go?
Topics: Alzheimer Disease; Brain; Cerebrovascular Circulation; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Positron emission tomography measures of benzodiazepine binding in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Benzodiazepines; Brain; Cerebrovascular Circulation; Deoxyglucose; Female; Flumazenil; Fluorodeoxyglucose F18; Glucose; Humans; Male; Receptors, GABA-A; Tomography, Emission-Computed | 1995 |
Difference of regional cerebral metabolic pattern between presenile and senile dementia of the Alzheimer type: a factor analytic study.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebellum; Cerebral Cortex; Dementia; Deoxyglucose; Factor Analysis, Statistical; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Organ Specificity; Tomography, Emission-Computed | 1994 |
Anatomic standardization: linear scaling and nonlinear warping of functional brain images.
Topics: Algorithms; Alzheimer Disease; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Oxygen Radioisotopes; Reference Standards; Tomography, Emission-Computed; Water | 1994 |
Stereotactic PET atlas of the human brain: aid for visual interpretation of functional brain images.
Topics: Adult; Alzheimer Disease; Brain; Brain Mapping; Contrast Media; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Reference Values; Stereotaxic Techniques; Tomography, Emission-Computed | 1994 |
Altered cerebral energy metabolism in Alzheimer's disease: a PET study.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cerebrovascular Circulation; Contrast Media; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Oxygen Consumption; Tomography, Emission-Computed | 1994 |
Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Contrast Media; Deoxyglucose; Diagnosis, Computer-Assisted; Diagnosis, Differential; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Neural Networks, Computer; ROC Curve; Tomography, Emission-Computed | 1994 |
High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer's disease: comparison with fluorine-18-FDG PET.
Topics: Adult; Aged; Alzheimer Disease; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organotechnetium Compounds; Oximes; Technetium Tc 99m Exametazime; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1994 |
Comparability of FDG PET studies in probable Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed | 1993 |
Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Atrophy; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed | 1993 |
Early detection of Alzheimer's disease: a statistical approach using positron emission tomographic data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Discriminant Analysis; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1993 |
PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Carbon Radioisotopes; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Isoquinolines; Male; Microglia; Receptors, GABA-A; Tomography, Emission-Computed | 1995 |
The relationship between psychiatric symptoms and regional cortical metabolism in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Arousal; Blood Glucose; Brain Mapping; Cerebral Cortex; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1995 |
Visual versus auditory memory stimulation in patients with probable Alzheimer's disease. A PET study with 18 FDG.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Memory; Middle Aged; Neuropsychological Tests; Pattern Recognition, Visual; Sound; Tissue Distribution; Tomography, Emission-Computed | 1996 |
Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET.
Topics: Aged; Alzheimer Disease; Biological Transport, Active; Brain; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hexokinase; Humans; Image Processing, Computer-Assisted; Male; Models, Theoretical; Phosphorylation; Tomography, Emission-Computed | 1996 |
Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Volume; Brain; Cerebrovascular Circulation; Dementia; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Middle Aged; Tomography, Emission-Computed | 1995 |
A human friendly reporting and database system for brain PET analysis.
Topics: Alzheimer Disease; Brain; Brain Diseases; Computer Graphics; Computer Systems; Data Interpretation, Statistical; Databases, Factual; Deoxyglucose; Epilepsy, Temporal Lobe; Evaluation Studies as Topic; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Supranuclear Palsy, Progressive; Tissue Distribution; Tomography, Emission-Computed | 1996 |
Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuropsychological Tests; Prognosis; Psychomotor Performance; Tomography, Emission-Computed; Vision Disorders; Visual Cortex | 1996 |
Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Educational Status; Female; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Intelligence; Intelligence Tests; Male; Neuropsychological Tests; Parietal Lobe; Psychiatric Status Rating Scales; Regression Analysis; Tomography, Emission-Computed | 1997 |
Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.
Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Case-Control Studies; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Parkinson Disease; Stereotaxic Techniques; Tomography, Emission-Computed | 1997 |
Reduction of cerebellar glucose metabolism in advanced Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Cerebellum; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Tomography, Emission-Computed | 1997 |
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Memory; Prospective Studies; Psychiatric Status Rating Scales; Radiopharmaceuticals; Stereotaxic Techniques; Time Factors; Tissue Distribution; Tomography, Emission-Computed | 1997 |
Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.
Topics: Acoustic Stimulation; Adult; Age Factors; Alzheimer Disease; Auditory Perception; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Motion Pictures; Parietal Lobe; Photic Stimulation; Risk Factors; Temporal Lobe; Tomography, Emission-Computed; Visual Perception | 1997 |
Decreased brain glucose metabolism in microvessels from patients with Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Animals; Brain; Deoxyglucose; Glucose; Hexokinase; Humans; Kinetics; Microcirculation; Middle Aged; Phosphorylation; Tomography, Emission-Computed | 1997 |
Evaluation of standardized uptake value to assess cerebral glucose metabolism.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Glucose; Humans; Male; Tomography, Emission-Computed | 2000 |
Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein.
Topics: Age Factors; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Cerebrovascular Circulation; Deoxyglucose; Glucose; Mice; Mice, Transgenic; Prosencephalon; Time Factors | 1999 |
Modulation of presenilin-1 processing by nitric oxide during apoptosis induced by serum withdrawal and glucose deprivation.
Topics: Alzheimer Disease; Apoptosis; Benzoates; Culture Media, Serum-Free; Cytochrome c Group; Deoxyglucose; Glioma; Glucose; Humans; Hypoglycemia; Imidazoles; Membrane Proteins; Mitochondria; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Penicillamine; Presenilin-1; Protein Processing, Post-Translational; S-Nitroso-N-Acetylpenicillamine; Tumor Cells, Cultured | 1999 |
Selective antibody-induced cholinergic cell and synapse loss produce sustained hippocampal and cortical hypometabolism with correlated cognitive deficits.
Topics: Alzheimer Disease; Animals; Antibodies, Monoclonal; Autoradiography; Behavior, Animal; Cerebral Cortex; Cholinergic Agents; Cognition Disorders; Deoxyglucose; Disease Models, Animal; Female; Glucose; Hippocampus; Immunotoxins; In Vitro Techniques; Injections, Intraventricular; Maze Learning; N-Glycosyl Hydrolases; Neurons; Piperidines; Rats; Rats, Sprague-Dawley; Receptor, Nerve Growth Factor; Receptors, Nerve Growth Factor; Ribosome Inactivating Proteins, Type 1; Saporins; Synapses; Wakefulness | 2001 |
Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease.
Topics: Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Memory; Occipital Lobe; Tomography, Emission-Computed | 1992 |
Reliability of drawing regions of interest for positron emission tomographic data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Flow Velocity; Blood Glucose; Brain; Brain Mapping; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Models, Anatomic; Observer Variation; Radiation Dosage; Reproducibility of Results; Tomography, Emission-Computed | 1992 |
A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Brain; Cerebral Cortex; Dementia; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Models, Anatomic; Neuropsychological Tests; Quinuclidinyl Benzilate; Receptors, Cholinergic; Reference Values; Regional Blood Flow; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1992 |
Positron emission tomography in degenerative disorders of the dopaminergic system.
Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed | 1992 |
Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjects.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Brain Mapping; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Energy Metabolism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Neuropsychological Tests; Neurotransmitter Agents; Tomography, Emission-Computed | 1991 |
Positron emission tomography and familial Alzheimer's disease: a pilot study.
Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Pilot Projects; Tomography, Emission-Computed | 1992 |
Abnormalities of energy metabolism in Alzheimer's disease studied with PET.
Topics: Adult; Aged; Aging; Alzheimer Disease; Brain; Deoxyglucose; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Parasympathomimetics; Piracetam; Succinimides; Tomography, Emission-Computed; Vision, Ocular | 1991 |
Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: a preliminary report.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Deoxyglucose; Depressive Disorder; Diagnosis, Differential; Energy Metabolism; Fluorodeoxyglucose F18; Frontal Lobe; Hippocampus; Humans; Tomography, Emission-Computed | 1991 |
Coronal reconstruction images of glucose metabolism in Alzheimer's disease.
Topics: Adult; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Glucose; Humans; Intelligence; Male; Middle Aged; Occipital Lobe; Organ Specificity; Parietal Lobe; Tomography, Emission-Computed | 1991 |
Altered glucose metabolism in microvessels from patients with Alzheimer's disease.
Topics: Alzheimer Disease; Blood-Brain Barrier; Brain; Capillaries; Deoxyglucose; Humans | 1991 |
Temporal and hippocampal metabolic rate during an olfactory memory task assessed by positron emission tomography in patients with dementia of the Alzheimer type and controls. Preliminary studies.
Topics: Aged; Alzheimer Disease; Deoxyglucose; Discrimination, Psychological; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; Psychomotor Performance; Smell; Temporal Lobe; Tomography, Emission-Computed; Visual Perception | 1991 |
Diminished glucose transport in Alzheimer's disease: dynamic PET studies.
Topics: Aged; Alzheimer Disease; Biological Transport; Brain; Cerebral Cortex; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Kinetics; Middle Aged; Phosphorylation; Temporal Lobe; Tomography, Emission-Computed | 1991 |
High-resolution PET studies in Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Organ Specificity; Reference Values; Tomography, Emission-Computed | 1991 |
Impaired metabolic activation in Alzheimer's disease: a PET study during continuous visual recognition.
Topics: Alzheimer Disease; Brain Chemistry; Cognition; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Psychological Tests; Psychomotor Performance; Tomography, Emission-Computed; Vision, Ocular | 1991 |
Characteristics of cerebral glucose utilization in dementia.
Topics: Aged; Alzheimer Disease; Brain; Cerebral Infarction; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Reference Values; Tomography, Emission-Computed | 1990 |
Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Frontal Lobe; Humans; Male; Neuropsychological Tests; Tomography, Emission-Computed | 1990 |
18Fluorodeoxyglucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychological Tests; Tomography, Emission-Computed | 1990 |
Clinical evaluation of a high-resolution (2.6-mm) positron emission tomography.
Topics: Alzheimer Disease; Brain; Brain Diseases; Brain Neoplasms; Deoxyglucose; Epilepsy, Temporal Lobe; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Humans; Necrosis; Radiation Injuries; Tomography, Emission-Computed | 1990 |
Positron emission tomography as an imaging tool in psychiatric disorders.
Topics: Alzheimer Disease; Blood Glucose; Brain; Dementia; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Huntington Disease; Tomography, Emission-Computed | 1989 |
PET-deoxyglucose, CT, and neuropathology of age-related white matter pathology in normals and Alzheimer's patients.
Topics: Adult; Aged; Alzheimer Disease; Blood Glucose; Brain; Cerebral Cortex; Cerebral Ventricles; Deoxyglucose; Humans; Middle Aged; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1989 |
Sensitivity and specificity of positron emission tomography and magnetic resonance imaging studies in Alzheimer's disease and multi-infarct dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Dementia, Multi-Infarct; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Radionuclide Imaging | 1989 |
Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset.
Topics: Age Factors; Aged; Alzheimer Disease; Brain; Caudate Nucleus; Deoxyglucose; Diagnosis, Differential; Female; Fluorine Radioisotopes; Functional Laterality; Glucose; Humans; Male; Menopause; Middle Aged; Parietal Lobe; Sex Factors; Thalamus | 1989 |
Altered glucose metabolism in microvessels from patients with Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Blood Vessels; Deoxy Sugars; Deoxyglucose; Energy Metabolism; Hexokinase; Humans; In Vitro Techniques; Middle Aged; Phosphorylation; Temporal Lobe | 1989 |
Crossed cerebellar and uncrossed basal ganglia and thalamic diaschisis in Alzheimer's disease.
Topics: Alzheimer Disease; Basal Ganglia; Brain; Cerebellum; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Middle Aged; Reference Values; Thalamus; Tomography, Emission-Computed | 1989 |
Cortical glutaminase, beta-glucuronidase and glucose utilization in Alzheimer's disease.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Glucuronidase; Glutaminase; Humans; Middle Aged; Tomography, Emission-Computed | 1989 |
Regional cerebral glucose transport and utilization in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Biological Transport; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Kinetics; Male; Middle Aged; Tissue Distribution; Tomography, Emission-Computed | 1989 |
Neurotransmitter receptor imaging in Alzheimer's disease.
Topics: Alzheimer Disease; Brain; Carbon Radioisotopes; Deoxyglucose; Flumazenil; Humans; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, GABA-A; Salicylamides; Tomography, Emission-Computed | 1987 |
Neuroimaging and dementia.
Topics: Alzheimer Disease; Atrophy; Brain; Brain Neoplasms; Cerebral Angiography; Dementia; Deoxyglucose; Fluorine; Humans; Huntington Disease; Hydrocephalus; Magnetic Resonance Spectroscopy; Pneumoencephalography; Radioisotopes; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.
Topics: Aging; Alzheimer Disease; Brain; Deoxyglucose; Down Syndrome; Fluorodeoxyglucose F18; Glucose; Humans; Memory; Oxygen Consumption; Radioisotopes; Tomography, Emission-Computed | 1986 |
Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
Topics: Adolescent; Adult; Alzheimer Disease; Brain; Caudate Nucleus; Deoxyglucose; Fluorodeoxyglucose F18; Glucose; Humans; Huntington Disease; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1985 |
Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type.
Topics: Aged; Alzheimer Disease; Arousal; Attention; Blood Glucose; Cerebral Cortex; Deoxyglucose; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1988 |
Cerebral mapping of apraxia in Alzheimer's disease by positron emission tomography.
Topics: Aged; Alzheimer Disease; Apraxias; Brain Mapping; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neural Pathways; Psychomotor Performance; Tomography, Emission-Computed | 1986 |
Positron emission tomography in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Atrophy; Dementia; Deoxyglucose; Electroencephalography; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Occipital Lobe; Parietal Lobe; Psychiatric Status Rating Scales; Psychological Tests; Rest; Temporal Lobe; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Comparison of PET, MRI, and CT with pathology in a proven case of Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Atrophy; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Gliosis; Humans; Magnetic Resonance Spectroscopy; Male; Neurofibrils; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
Towards a behavioral typology of Alzheimer's patients.
Topics: Adult; Aged; Alzheimer Disease; Cerebral Cortex; Cognition; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1986 |
Abnormal temporal lobe response in Alzheimer's disease during cognitive processing as measured by 11C-2-deoxy-D-glucose and PET.
Topics: Aged; Alzheimer Disease; Analysis of Variance; Carbon Radioisotopes; Cognition; Deoxyglucose; Glucose; Humans; Memory; Middle Aged; Temporal Lobe; Tomography, Emission-Computed | 1987 |
Cerebral metabolism, anatomy, and cognition in monozygotic twins discordant for dementia of the Alzheimer type.
Topics: Alzheimer Disease; Brain; Cognition Disorders; Deoxyglucose; Diseases in Twins; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed; Tomography, X-Ray Computed; Twins, Monozygotic | 1987 |
Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Tomography, Emission-Computed | 1987 |
The effect of diazepam sedation on cerebral glucose metabolism in Alzheimer's disease as measured using positron emission tomography.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Deoxyglucose; Diazepam; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, Emission-Computed | 1987 |
Dominantly inherited Alzheimer's disease: cerebral glucose metabolism.
Topics: Adult; Alzheimer Disease; Blood Glucose; Brain; Deoxyglucose; Female; Fluorodeoxyglucose F18; Genes, Dominant; Humans; Middle Aged; Pedigree; Tomography, Emission-Computed | 1987 |
Metabolic aspects of aging brain and related disorders.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aging; Alzheimer Disease; Animals; Brain; Cerebral Cortex; Deoxy Sugars; Deoxyglucose; Humans; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C57BL; Parkinson Disease; Pyridines; Rats; Rats, Inbred Strains; Superoxide Dismutase; Tomography, Emission-Computed | 1987 |
Cerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain Neoplasms; Cerebellum; Cerebral Infarction; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Middle Aged; Sense Organs; Sensory Deprivation; Tomography, Emission-Computed | 1987 |
Neuropsychological and cerebral metabolic function in early vs late onset dementia of the Alzheimer type.
Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Cerebral Cortex; Concept Formation; Deoxyglucose; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Tomography, Emission-Computed | 1987 |
Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization.
Topics: Alzheimer Disease; Cerebral Cortex; Deoxyglucose; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Temporal Lobe; Tomography, Emission-Computed | 1985 |
Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia.
Topics: Age Factors; Aged; Alzheimer Disease; Brain; Deoxyglucose; Dominance, Cerebral; Female; Fluorine; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Radioisotopes; Tomography, Emission-Computed; Wechsler Scales | 1985 |
Determinations of cerebral glucose utilization in dementia using positron emission tomography.
Topics: Aged; Alzheimer Disease; Basal Ganglia Diseases; Blood Glucose; Dementia; Deoxyglucose; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Tomography, Emission-Computed | 1985 |
Clinical history, brain metabolism, and neuropsychological function in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Cerebrovascular Circulation; Deoxyglucose; Female; Humans; Male; Middle Aged; Neurons; Neuropsychological Tests; Tomography, Emission-Computed | 1985 |
Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Psychological Tests; Tomography, Emission-Computed | 1985 |
Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia.
Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cerebral Ventricles; Deoxyglucose; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Hydrocephalus; Hydrocephalus, Normal Pressure; Intracranial Aneurysm; Male; Middle Aged; Subarachnoid Hemorrhage; Tomography, Emission-Computed | 1985 |
Patterns of cerebral glucose utilization in depression, multiple infarct dementia, and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Brain; Dementia; Deoxyglucose; Depressive Disorder; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Tomography, X-Ray Computed | 1985 |